Use caution Drug recall · FDA · Published January 21, 2026

Unichem Recalls Doxazosin 4mg Tablets Due to Wrong ID Imprint

Unichem Pharmaceuticals recalls 60,000 bottles of Doxazosin Tablets USP 4 mg because tablets are imprinted with the wrong identification code.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0306-2026Drug Unichem Pharmaceuticals ›

Use caution until it’s fixed

Tablets/Capsules Imprinted with Wrong ID

Take action

Contact the company

Recalling firmUnichem Pharmaceuticals USA Inc.1 Tower Center Blvd Ste 2200 · East Brunswick, NJ 08816-1145

✎ GovInfoNow plain-language explainer

Unichem Pharmaceuticals USA Inc. is recalling Doxazosin Tablets, USP, 4 mg, distributed nationwide. The recall was issued because the tablets in the affected bottles are imprinted with the wrong identification code. This error could lead to medication confusion for patients and pharmacists. Read more at govinfonow.com/recall/31529-unichem-recalls-doxazosin-4mg-tablets-due-to-wrong-id-imprint.

Source Summary by GovInfoNow · govinfonow.com/recall/31529-unichem-recalls-doxazosin-4mg-tablets-due-to-wrong-id-imprint · Updated October 9, 2026 · FDA enforcement record: FDA #D-0306-2026

Cite this page

“Unichem Recalls Doxazosin 4mg Tablets Due to Wrong ID Imprint.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/31529-unichem-recalls-doxazosin-4mg-tablets-due-to-wrong-id-imprint. Based on FDA recall #D-0306-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0306-2026%22&limit=1).

The FDA announced on Jan. 21, 2026, that Unichem Pharmaceuticals USA Inc. is recalling Doxazosin Tablets, USP, 4 mg due to tablets being imprinted with the wrong identification marks. The voluntary Class III recall affects 60,000 tablets distributed nationwide.

How to tell if you have it

Brand: Unichem Pharmaceuticals
Product: Doxazosin Tablets, USP, 4 mg
Quantity: 1000 tablets per bottle
NDC: 29300-353-10
Lot #: GDSH25006
Expiration Date: 08/2027

The hazard

The hazard involves tablets and capsules imprinted with the wrong identification. The FDA classified this as a Class III recall.

Context

GovInfoNow's records show Unichem Pharmaceuticals USA Inc. has 11 other recalls on record since July 30, 2015. Other recent recalls of similar products include SpecGx Oxycodone/Acetaminophen Tablets Recall (Dec. 16, 2025), American Health Packaging Buprenorphine Tablets Recall (Aug. 19, 2026), and Annora Pharma Lacosamide Tablets Recall (June 4, 2026).

How to tell if you have this one

Check your bottle for Doxazosin Tablets, USP, 4 mg, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc. Look specifically for NDC 29300-353-10 and Lot # GDSH25006 with an expiration date of 08/2027.

Brand
Unichem Pharmaceuticals
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check your medication bottle
Verify if your Doxazosin Tablets match NDC 29300-353-10 and Lot # GDSH25006 with Exp Date 08/2027.
Contact your pharmacist
If you have the recalled product, speak with your pharmacy or healthcare provider for instructions on replacement or return.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 28 days after the firm started it.

Jan 21, 2026Firm started the recall
Feb 11, 2026FDA classified it Class III
Feb 18, 2026Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Unichem Pharmaceuticals recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/31529-unichem-recalls-doxazosin-4mg-tablets-due-to-wrong-id-imprint">Unichem Recalls Doxazosin 4mg Tablets Due to Wrong ID Imprint (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0306-2026 (January 21, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0306-2026 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.